Skip to Content

Creative Edge Nutrition Inc FITX

Morningstar Rating
$0.00 0.00 (100.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FITX is trading at a 857% premium.
Price
$0.00
Fair Value
$8.38
Uncertainty
Extreme
1-Star Price
$9.16
5-Star Price
Economic Moat
Vsk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FITX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$9,495.99
Volume/Avg
11,100 / 181,887

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Creative Edge Nutrition Inc is nutritional supplement company focusing on active lifestyles. It is engaged in the development of nutraceuticals and supplements. The company offers a range of tablets, capsules, and powders as well as science based products in weight management, specific nutrition challenges, energy and fitness categories. It markets and sells its products under brand names such as Alpha drive, Aminoplex, Hemp plex, and Centro plex.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
3

Valuation

Metric
FITX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
FITX
Quick Ratio
0.27
Current Ratio
0.27
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
FITX
Return on Assets (Normalized)
−127.76%
Return on Equity (Normalized)
−814.73%
Return on Invested Capital (Normalized)
−400.42%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
YkqkylhfVwhkc$82.1 Bil
Merck KGaA ADR
MKKGY
QryxqppfpLndsqnz$75.2 Bil
Haleon PLC ADR
HLN
WbykpdmKwct$41.4 Bil
Viatris Inc
VTRS
MjgcrlrkGqh$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
XgbywhclxHggj$13.7 Bil
Catalent Inc
CTLT
RjsfffvxHyhtn$10.6 Bil
Perrigo Co PLC
PRGO
CnzbdcdzWfvhy$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
QbqllcgtNrybwrm$3.5 Bil
Curaleaf Holdings Inc
CURLF
KzfpkhxwDmqw$3.0 Bil
Green Thumb Industries Inc
GTBIF
FgllgrdbKbmlx$2.7 Bil

Sponsor Center